Literature DB >> 7607208

Mutations at the C-terminal isoleucine and other potential iron ligands of 5-lipoxygenase.

T Hammarberg1, Y Y Zhang, B Lind, O Radmark, B Samuelsson.   

Abstract

The non-heme iron centre in human 5-lipoxygenase was studied. Recombinant enzyme was expressed in Escherichia coli, purified and assayed for iron content and enzyme activity. For non-mutated enzyme, the iron content was 1.01 +/- 0.19 mol/mol. Deletion of the C-terminal Ile673 resulted in an iron content of 0.03 +/- 0.07 mol/mol and undetectable lipoxygenase activity. Mutations at His367, Glu376 and Asn554 led to drastically decreased enzyme activity (< 2% of non-mutated control) but iron was still present. In addition to Glu376, eight other conserved acidic residues (Asp/Glu) in 5-lipoxygenase were replaced, none of which was crucial for enzyme activity. We conclude that Ile673 is an iron ligand in 5-lipoxygenase, while our results do not support that Glu376 or Asn554 have this function. The possible role of His367 as a replaceable iron ligand is discussed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7607208     DOI: 10.1111/j.1432-1033.1995.0401h.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  7 in total

1.  Molecular pharmacological profile of a novel thiazolinone-based direct and selective 5-lipoxygenase inhibitor.

Authors:  B Hofmann; C B Rödl; A S Kahnt; T J Maier; A A Michel; M Hoffmann; O Rau; K Awwad; M Pellowska; M Wurglics; M Wacker; A Zivković; I Fleming; M Schubert-Zsilavecz; H Stark; G Schneider; D Steinhilber
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

2.  The iron ligand sphere geometry of mammalian 15-lipoxygenases.

Authors:  R J Kuban; R Wiesner; J Rathman; G Veldink; H Nolting; V A Solé; H Kühn
Journal:  Biochem J       Date:  1998-05-15       Impact factor: 3.857

3.  5-lipoxygenase is phosphorylated by p38 kinase-dependent MAPKAP kinases.

Authors:  O Werz; J Klemm; B Samuelsson; O Rådmark
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

4.  Analysis of a nucleotide-binding site of 5-lipoxygenase by affinity labelling: binding characteristics and amino acid sequences.

Authors:  Y Y Zhang; T Hammarberg; O Radmark; B Samuelsson; C F Ng; C D Funk; J Loscalzo
Journal:  Biochem J       Date:  2000-11-01       Impact factor: 3.857

5.  Homology modeling of 5-lipoxygenase and hints for better inhibitor design.

Authors:  P Aparoy; R N Reddy; Lalitha Guruprasad; M R Reddy; P Reddanna
Journal:  J Comput Aided Mol Des       Date:  2008-01-30       Impact factor: 3.686

6.  Inhibition of lipoxygenases and cyclooxygenases by linoleyl hydroxamic acid: comparative in vitro studies.

Authors:  Igor A Butovich; Svetlana M Lukyanova
Journal:  J Lipid Res       Date:  2008-02-27       Impact factor: 5.922

7.  LeadOp+R: Structure-Based Lead Optimization With Synthetic Accessibility.

Authors:  Fang-Yu Lin; Emilio Xavier Esposito; Yufeng J Tseng
Journal:  Front Pharmacol       Date:  2018-03-05       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.